Proton therapy safer than older radiotherapies for esophageal cancer
the ONA take:
According to new researcher presented at the annual conference of the Particle Therapy Cooperative Group in San Diego, California, researchers from the University of Maryland School of Medicine in Baltimore have found that patients with esophageal cancer treated with proton therapy experienced significantly fewer adverse events than patients treated with conventional radiation therapies.
For the study, researchers identified about 600 patients with esophageal cancer and found that proton therapy was associated with significantly fewer incidents of nausea, blood abnormalities, and loss of appetite than older radiation therapies.
Proton therapy has shown efficacy in various types of cancer, including brain, breast, esophageal, head and neck, liver, lung, prostate, and spinal cord cancers. It is expected that up to 30% of patients with cancer will benefit from targeted proton beam therapy, which can precisely target tumors while reducing radiation to healthy issue.
"This evidence underscores the precision of proton therapy, and how it can really make a difference in cancer patients' lives," said Michael Chuong, MD, an assistant professor of radiation oncology at the University of Maryland School of Medicine.
Patients with esophageal cancer treated with proton therapy experienced significantly fewer adverse events.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|